Complete the form below to receive more information about how CRI Genetics PGx can help you.
Please select either Patient or Cardiologist.
Every patient is an individual with unique traits and needs. Using DNA, our pharmacogenomics panel helps reveal how your patients react to medications and treatments.
Simply put, you will know ahead of time which treatment may have a stronger chance to help your patient with their particular condition - and which potentially harmful treatments to avoid.
CRI Genetics PGx will save time and frustration for you and your patients.
With the foresight gained by a pharmacogenomics panel for your patient, you may be able to diagnose your patient and find an effective treatment much faster.
One third of patients stop taking medication without telling their doctors. 29% of them stop due to side effects. 15% stop because they don’t think it works.
Pharmacogenomics gives you an advantage that can make a real difference.
If we can bring pharmacogenomics to the frontlines of medicine, I think we have a better chance of managing health instead of managing disease. read more
Russ Atman, MD, PhD, Stanford Medicine
It’s an effort to individualize—to personalize—our use of drugs. read more
Richard Weinshilboum, MD, Mayo Clinic
The ultimate goal of personalized medicine is to come up with the right drug for the right patient at the right time. read more
Dr. Jerome Rotter, MD, UCLA Medical Center
Our mission at CRI Genetics (Cellular Research Institute, Genetics Department) is to unlock complex information from DNA and present it in a way that’s interesting, useful, and easy to understand. We want to help people learn more about themselves and find ways to improve lives through genetic testing.
Our primary goal is to further Mankind’s understanding of the human genome. Not only do we provide advanced genetic reports to consumers,but we also actively participate in scientific research. We believe genetic analysis is the future of medicine and we’re excited to play a role in solving complex medical problems.
Pharmacogenomics is the study of how inheritable genetic differences in individuals can affect how they react to medications and treatments. Every person is different and may metabolize, absorb, and respond to treatments in individual ways that are determined by their DNA. PGx is meant to be a tool for doctors to reference in treating patients that allows them to have an idea as to how a patient may metabolize, absorb, and respond to particular treatments. The goal is to reduce trial and error and improve patient care overall.
A CRI Genetics PGx test panel will help you determine whether a patient is at greater risk for side effects or who may benefit more/less from a particular medication. You will find the right treatment for your patient much faster than the traditional “trial & error” methods of diagnosis and treatment.
A CRI Genetics PGx test panel will provide actionable data for 322 drugs and over 60 genes. The information within will include potential disease risks, likely metabolism for medications, and drug-gene interaction risks.
Any patient who may begin treatment with one of the 322 medications in our panel. Alternatively, if you have a patient who is struggling to achieve the desired result from multiple “trial and error” attempts at treatment, that is a perfect patient for a CRI Genetics PGx test panel.
Your doctor will have access to your reports within 3-4 weeks from the time when our lab receives your DNA sample. Results will be viewable (and printable) within a simple, secure online portal.
